Skip to content

144Accepted Oct 18, 4:39 PM ET

Janux Therapeutics, Inc. 144

Avalon BioVentures SPV I, L.P.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:39 PM

Oct 18, 2024

Filed

Oct 18, 2024

Documents

1

Size

8.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.